Medicenna Therapeutics Corp.
MDNAF
$0.7212
-$0.0228-3.07%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.37% | -9.99% | -24.75% | -261.74% | -335.19% |
| Total Depreciation and Amortization | 1,742.86% | 1,057.14% | 428.57% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 351.67% | 51.41% | 135.91% | 1,732.05% | 107.41% |
| Change in Net Operating Assets | -26.90% | -339.40% | 143.58% | -180.62% | 17.84% |
| Cash from Operations | 14.18% | -40.78% | 34.10% | -112.16% | -9.84% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 1,119.35% | -4,046.15% | 120.87% | 189.98% | 128.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 89.36% | -30.26% | 559.85% | -87.38% | -1.66% |
